Origin Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,223
Closed -$804K 143
2016
Q4
$804K Hold
11,223
0.05% 93
2016
Q3
$888K Sell
11,223
-181,463
-94% -$14.7M 0.06% 97
2016
Q2
$16.1M Sell
192,686
-91,600
-32% -$8.13M 1.07% 30
2016
Q1
$26.1M Sell
284,286
-2,256
-0.8% -$203K 1.82% 18
2015
Q4
$29M Sell
286,542
-5,000
-2% -$520K 2.35% 7
2015
Q3
$28.6M Sell
291,542
-12,887
-4% -$1.43M 2.37% 9
2015
Q2
$35.6M Buy
304,429
+52,636
+21% +$5.75M 2.59% 6
2015
Q1
$24.7M Sell
251,793
-55,921
-18% -$5.68M 1.82% 13
2014
Q4
$29M Sell
307,714
-93,776
-23% -$9.7M 2.21% 4
2014
Q3
$42.7M Sell
401,490
-43,200
-10% -$4.23M 2.77% 3
2014
Q2
$36.9M Buy
444,690
+100,090
+29% +$7.79M 2.38% 5
2014
Q1
$24.4M Buy
344,600
+169,600
+97% +$13.3M 1.62% 25
2013
Q4
$13.2M Buy
+175,000
New +$12.2M 0.88% 48

Other funds holding GILD

Origin Asset Management's GILD Position: Q1 2017 in Review

Origin Asset Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 11,223 shares — an estimated $804K sold.

Origin Asset Management first reported a position in GILD in Q4 2013 and held it in 13 quarters. The position peaked at $42.7M in Q3 2014. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Origin Asset Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Origin Asset Management sold 11,223 Gilead Sciences shares in Q1 2017, an estimated $804K.
  • Origin Asset Management first reported a position in Gilead Sciences in Q4 2013 and held it in 13 quarters.
  • Origin Asset Management's Gilead Sciences position peaked at $42.7M in Q3 2014.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Origin Asset Management's 13F filing for Q1 2017, filed 11 May 2017.